Amazon is positioned to outperform mega-cap peers, driven by its expansive data center footprint and AI infrastructure ...
AstraZeneca's Calquence has hit the mark in the phase 3 AMPLIFY trial in chronic lymphocytic leukaemia (CLL), a study that chief executive Pascal Soriot recently said could be a "blockbuster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback